跳至主要内容
临床试验/NCT00660634
NCT00660634已完成4 期

The Effect of Angioplasty in Peripheral Arterial Disease on Endothelial Function

Insel Gruppe AG, University Hospital Bern0 个研究点目标入组 33 人开始时间: 2004年12月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
33
主要终点
Improvement of Flow-mediated Dilation

研究概览

简要总结

To investigate whether endovascular revascualrization of infrainguinal arterial obstructive disease has an effect on brachial artery reactivity

详细描述

Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis affecting a large proportion of the aged population. It is associated with a more or less severe impairment in functional activity and with an increased risk of future cardiovascular events. In PAD patients, an increased inflammatory status and a depressed endothelial function, assessed as flow-mediated dilation of the brachial artery have been demonstrated. Moreover, a prognostic value has been found in PAD patients for both inflammatory parameter and flow-mediated dilation (FMD). One of the reasons of the increased inflammatory activation and endothelial dysfunction in PAD patients could be the ischemia-reperfusion injury associated with intermittent claudication. The hypothesis is that repeated episodes of acute inflammation and endothelial dysfunction following ischemia-reperfusion injury linked to intermittent claudication could be in part responsible for the increased inflammatory status and chronically depressed endothelial dysfunction of these patients. Taking into account these considerations, it is reasonable to assume that the correction of leg ischemia by interventional procedure, such as peripheral transluminal angioplasty (PTA) should determine a reduction in inflammatory mediators and an improvement in endothelial function.

The study is a prospective, open, randomised, controlled, single-centre, follow-up evaluation, assessing the efficacy of peripheral catheter interventions in patients with symptomatic PAD on endothelial dysfunction and plasmatic procoagulant activity. Patients will be randomly assigned to immediate revascularization or to no treatment for one month. The assessment of parameters (brachial artery flow-mediated and nitrate-mediated dilation, plasma levels of C reactive protein, fibrinogen, microparticles and coagulation factors) will be performed at baseline and after 4 weeks in both, patients undergoing interventional procedures and in those, who will not be treated.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Peripheral arterial disease
  • femoro-popliteal lesion
  • successful endovascular treatment of lesion

排除标准

  • persistent claudication after revascularization in arm A
  • inflammatory or neoplastic disease
  • pregnancy

结局指标

主要结局

Improvement of Flow-mediated Dilation

时间窗: 4 weeks

次要结局

  • Improvement of white blood cell count(4 weeks)

研究者

申办方类型
Other

相似试验